US Pharma MarketingThe post Freenome’s lung cancer test receives FDA breakthrough status appeared first on Medical Device Network.
Freenome’s lung cancer test receives FDA breakthrough status
Freenome has secured breakthrough device designation from the FDA for its investigational, blood-based SimpleScreen Lung test for adults. The post Freenome’s lung cancer test receives FDA breakthrough status appeared first on Medical Device Network .
Freenome has secured breakthrough device designation from the FDA for its investigational, blood-based SimpleScreen Lung test for adults.
Source: Medical Device Network